Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 7Recruiting 3Unknown 1Terminated 1No longer available 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

CNS 2Tumor-Agnostic 1

Conditions

Glioma 2Neoplasm Metastasis 1Adenocarcinoma 1

Interventions

pembrolizumab 563Specimen Handling 493Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 405Radiotherapy 353Bevacizumab 314Gemcitabine 313Paclitaxel 298Biopsy 292Drug Therapy 284Blood Specimen Collection 248Capecitabine 246Oxaliplatin 241fludarabine 239Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 188Radiosurgery 182Standard of Care 159Rituximab 159Pemetrexed 156Surgical Procedures, Operative 148atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Cancer Vaccines × Clear all
NCT05101356 2024-05-21

A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma

University of California, Davis

Phase 1/2 Recruiting
77 enrolled
Tumor-Agnostic

Adenocarcinoma, Neoplasm Metastasis

NCT06156150 2023-12-05

The Role of B7-H4 in Tumor Vaccine

Huashan Hospital

Recruiting
160 enrolled
CNS

Glioma

NCT06102837 2023-10-26

Tumor Vaccines for Solid Tumors

Huashan Hospital

Recruiting
340 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡